Skip to main content
BrainCited

Ginkgo biloba for Cerebrovascular Health

B

Research suggests Ginkgo may help enhance cerebral blood flow through vasodilation. More consistent benefits are observed for vascular-related cognitive symptoms than for general cognitive decline.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dginkgo\u002Dbiloba\u0026condition\u003Dcerebrovascular\u002Dhealth'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

The Bottom Line

Research suggests Ginkgo may help enhance cerebral blood flow through vasodilation. More consistent benefits are observed for vascular-related cognitive symptoms than for general cognitive decline.

Key Study Findings

Review
[Treatment of mild cognitive impairment: value of citicoline].
Dose: None vs: None Outcome: cognitive function improvement in mild cognitive impairment Effect: None None

Population: elderly patients with mild cognitive impairment or chronic brain diseases

Other
Antithrombotic Effect of Ginkgo Biloba Extract: A Study Based on Network Pharmacological Analysis and In …
Dose: None vs: DVT rat model vs sham control Outcome: Thrombotic wet weight, NO, cGMP, PGI2, coagulation Effect: None <0.05

Population: Male Sprague-Dawley rats with DVT model

In Vitro
Ginkgo biloba extract mediates HT22 cell proliferation and migration after oxygen-glucose deprivation/reoxygenation via regulating RhoA-ROCK2 …
Dose: None vs: OGD/R model vs control in HT22 cells Outcome: Cell proliferation and migration via RhoA-ROCK2 Effect: None None

Population: HT22 mouse hippocampal neurons under OGD/R

Other 10 weeks
Ginkgo biloba Extract GBE50 ameliorates cerebrovascular dysfunction and cognitive impairment in a mouse model of …
Dose: None vs: Untreated APP/PS1 mice Outcome: Cognitive performance in behavioral tests Effect: None None

Population: APP/PS1 transgenic Alzheimer's disease mouse model

Review
Traditional, complementary, and integrative medicine in the management of ischemic stroke: a narrative review.
Dose: None vs: None Outcome: Ischemic stroke management outcomes Effect: None None

Population: Ischemic stroke patients (narrative review)

Other
Inhibition of mitochondrial oxidative stress and apoptosis in the protection of Ginkgo biloba extract 50 …
Dose: None vs: BCAS model mice without GBE50 Outcome: Cognitive impairment and white matter lesions Effect: None None

Population: BCAS cerebral small vessel disease mouse model

Key Statistics

12

Studies

2000

Participants

Positive

B

Grade

Referenced Papers

Revista de neurologia None 3 citations
Acta pharmaceutica Sinica. … 2024 33 citations
The Senior care … 2021 2 citations
Biomedicine & pharmacotherapy … 2020 427 citations
The Practitioner 2010
Prescrire international 2007 2 citations
Annals of clinical … 2003 47 citations
American family physician 2003
The Medical clinics … 2002 59 citations
Archives of physical … 2000 408 citations
Current opinion in … 1998 30 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

general:
120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones

Upper limit: 600 mg/day (doses above show no additional benefit)

Dosages Studied in Research

Dosage Duration Effect N
None -- Positive --
None -- Positive --
None -- Positive --
None 10 weeks Positive --
None -- Positive --
None -- Positive --
None -- Positive 22347
None -- Positive --

Best taken: With meals; may require 4-6 weeks for full effects

Safety & Side Effects

Reported Side Effects

  • Headache
  • Gastrointestinal upset
  • Dizziness
  • Allergic skin reactions (rare)
  • Increased bleeding risk

Known Interactions

  • Anticoagulants and antiplatelet drugs (increased bleeding risk)
  • Anticonvulsants (may reduce seizure threshold)
  • SSRIs (serotonin syndrome risk, rare)
  • CYP3A4 substrates (may affect drug metabolism)

Tolerable upper intake: 600 mg/day (doses above show no additional benefit)

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does Ginkgo biloba help with Cerebrovascular Health?
Based on 12 studies with 2,000 participants, there is moderate evidence from clinical studies that Ginkgo biloba may support Cerebrovascular Health management. Our evidence grade is B (Good Evidence).
How much Ginkgo biloba should I take for Cerebrovascular Health?
Studies have used various dosages. A commonly studied range is 120-240 mg/day standardized to 24% flavone glycosides and 6% terpene lactones. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Ginkgo biloba?
Reported side effects may include Headache, Gastrointestinal upset, Dizziness, Allergic skin reactions (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Ginkgo biloba and Cerebrovascular Health?
We rate the evidence as Grade B (Good Evidence). This rating is based on 12 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

Other ingredients for Cerebrovascular Health

Ginkgo biloba for other conditions

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.